A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema
- 1 May 2017
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 139, 238-246
Abstract
No abstract availableKeywords
Funding Information
- Spanish Ministry of Economy and Competitiveness (CTQ2014-55279-R, PI13-01909)
- Spanish Society of Pulmonology and Thoracic Surgery (SEPAR-132, SEPAR 1004-2010)
This publication has 28 references indexed in Scilit:
- Sphingolipids as cell fate regulators in lung development and diseaseApoptosis, 2015
- Liver Growth Factor as a Tissue Regenerating Factor in Neurodegenerative DiseasesRecent Patents on CNS Drug Discovery, 2015
- Proliferative Activity of Liver Growth Factor is Associated with an Improvement of Cigarette Smoke-Induced Emphysema in MicePLOS ONE, 2014
- Liver growth factor treatment reverses emphysema previously established in a cigarette smoke exposure mouse modelAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- El factor de crecimiento de hígado mejora la fibrosis pulmonar inducida tras la administración de cadmio en ratasArchivos de Bronconeumología, 2010
- Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary DiseasePhysiological Reviews, 2007
- A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cellsProceedings of the National Academy of Sciences, 2007
- Role of apoptosis in the pathogenesis of COPD and pulmonary emphysemaRespiratory Research, 2006
- Apoptosis and EmphysemaAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Identification of a liver growth factor as an albumin-bilirubin complexBiochemical Journal, 1987